Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BLCO
BLCO logo

BLCO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bausch + Lomb Corp (BLCO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
17.100
1 Day change
-0.06%
52 Week Range
18.910
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BLCO is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is slightly above the previous close, but the technical setup is overbought and the upside signal is not strong enough to justify an aggressive entry today. I would not buy it now; I would wait for a better entry or stronger fundamental catalyst.

Technical Analysis

BLCO closed at 17.2471, up modestly from 17.16, with a positive MACD histogram (0.236) showing short-term momentum is improving. However, RSI_6 is 89.153, which is extremely overbought and suggests the move is stretched. Moving averages are converging, which usually points to a pending inflection rather than a clean trend. Price is also near resistance: R1 at 16.944 was already cleared, and R2 at 17.531 is the next major level, so upside from here looks limited in the near term. Overall trend is mildly bullish but technically extended.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is strongly bullish on open interest, with a very low put-call ratio of 0.09, indicating calls heavily outweigh puts. Option volume is minimal, though, so this is more a positioning signal than an active trading conviction signal. Implied volatility is elevated at 90.76, which suggests the market expects meaningful price movement, but the lack of meaningful volume and the absence of a fresh signal reduce confidence. No AI Stock Picker or SwingMax signal is present today.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
10

Positive Catalysts

  • ["Insiders are buying, and the buying amount increased 704.32% over the last month.", "Options positioning is bullish with a very low open interest put-call ratio of 0.09.", "MACD histogram is positive and expanding, showing improving momentum.", "The stock has recently traded above key pivot levels and is near the next resistance test.", "No negative news hit the stock in the last week."]

Neutral/Negative Catalysts

  • ["RSI is extremely overbought at 89.153, making the current price extension unattractive for a fresh entry.", "Analyst sentiment has weakened recently, with multiple price target cuts from Evercore ISI and Deutsche Bank.", "Wall Street is mixed to cautious overall, with Hold/In Line ratings dominating the latest updates.", "No recent news catalysts are present to support a stronger re-rating.", "No recent congress trading activity was reported."]

Financial Performance

No usable latest-quarter financial snapshot was provided, so there is no reliable quarter-over-quarter growth assessment available here. The latest seasonal quarter cannot be confirmed from the data. Because of that, the decision has to rely more on technicals, options, and sentiment than on current financial growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst direction has turned mildly negative: Evercore ISI cut its target to $16 from $17 and kept an In Line rating, Deutsche Bank cut its target to $16 from $18 and kept a Hold rating, and Citi lowered its target to C$19 from C$21 while keeping a Buy rating. Overall, Wall Street pros appear cautious rather than constructive, with more downgraded targets than upgrades and a consensus leaning toward Hold/In Line rather than strong buy.

Wall Street analysts forecast BLCO stock price to rise
10 Analyst Rating
Wall Street analysts forecast BLCO stock price to rise
4 Buy
5 Hold
1 Sell
Moderate Buy
Current: 17.110
sliders
Low
13
Averages
18.11
High
21
Current: 17.110
sliders
Low
13
Averages
18.11
High
21
Evercore ISI
In Line
maintain
$16 -> $17
AI Analysis
2026-07-06
New
Reason
Evercore ISI
Price Target
$16 -> $17
AI Analysis
2026-07-06
New
maintain
In Line
Reason
Evercore ISI raised the firm's price target on Bausch + Lomb to $17 from $16 and keeps an In Line rating on the shares. The firm's Q2 preview for MedTech, Life Sciences Tools, and Diagnostics highlights generally healthy procedure volumes and capital expenditure trends across the sector, the analyst tells investors in a research note.
Evercore ISI
Vijay Kumar
In Line
downgrade
$17 -> $16
2026-04-30
Reason
Evercore ISI
Vijay Kumar
Price Target
$17 -> $16
2026-04-30
downgrade
In Line
Reason
Evercore ISI analyst Vijay Kumar lowered the firm's price target on Bausch + Lomb to $16 from $17 and keeps an In Line rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BLCO
Unlock Now

People Also Watch